Table: begin end state 1 27 cytoplasmic 28 48 transmembrane 49 53 non-cytoplasmic 54 71 transmembrane 72 106 cytoplasmic 107 130 transmembrane 131 135 non-cytoplasmic 136 154 transmembrane 155 162 cytoplasmic 163 184 transmembrane 185 204 non-cytoplasmic 205 228 transmembrane 229 248 cytoplasmic 249 271 transmembrane 272 290 non-cytoplasmic 291 309 transmembrane 310 339 cytoplasmic 340 361 transmembrane 362 366 non-cytoplasmic 367 388 transmembrane 389 407 cytoplasmic 408 428 transmembrane 429 433 non-cytoplasmic 434 452 transmembrane 453 458 cytoplasmic
Input: >14712 FitnessBrowser__Keio:14712 MKNASTVSEDTASNQEPTLHRGLHNRHIQLIALGGAIGTGLFLGIGPAIQMAGPAVLLGY GVAGIIAFLIMRQLGEMVVEEPVSGSFAHFAYKYWGPFAGFLSGWNYWVMFVLVGMAELT AAGIYMQYWFPDVPTWIWAAAFFIIINAVNLVNVRLYGETEFWFALIKVLAIIGMIGFGL WLLFSGHGGEKASIDNLWRYGGFFATGWNGLILSLAVIMFSFGGLELIGITAAEARDPEK SIPKAVNQVVYRILLFYIGSLVVLLALYPWVEVKSNSSPFVMIFHNLDSNVVASALNFVI LVASLSVYNSGVYSNSRMLFGLSVQGNAPKFLTRVSRRGVPINSLMLSGAITSLVVLINY LLPQKAFGLLMALVVATLLLNWIMICLAHLRFRAAMRRQGRETQFKALLYPFGNYLCIAF LGMILLLMCTMDDMRLSAILLPVWIVFLFMAFKTLRRK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server